Madden, P.J., et al. Diverse priming outcomes under conditions of very rare precursor B cells.

In Scientific Papers

Madden, P.J., et al. Diverse priming outcomes under conditions of very rare precursor B cells.

Immunity, 2025 Apr 8, 58(4):997-1014.e11. PMID: 40168992

  • The paper investigates the recruitment and expansion of rare broadly neutralizing antibody-precursor B cells following immunization with HIV germline-targeting vaccines, focusing on the impact of delivery strategies and adjuvants, such as 1) Saponin and monophosphoryl lipid A (MPLA)-containing nanoparticle (SMNP), 2) Alum, 3) Nano-alum, 4) Amph-CpG. 
  • It demonstrates that escalating dose (ED) immunization combined with the saponin adjuvant SMNP significantly enhances the detection of BG18-like cells in germinal centers compared to other conditions. While all conditions elicited strong germinal center responses, only ED+SMNP and bolus+SMNP led to the generation of BG18-like memory B cells in over 50% of the animals studied. The results reveal that antibody feedback notably influences priming and affinity maturation of these rare B cells, highlighting the complexities of designing effective vaccination regimens to target rare precursor B cell populations and the essential role of immunogen affinity in overcoming their inherent rarity. 
  • The study highlights several important consequences of the use of saponin adjuvants, particularly the SMNP formulation: Enhanced immune responses, diversity of antibody responses, influence on immunological characteristics, and potential for clinical applications. The findings underscore the utility of saponin adjuvants in enhancing vaccine efficacy, particularly in the context of generating robust and broad antibody responses necessary for effective immunization against challenging pathogens. However, the study suggests that while saponin adjuvants like SMNP show promise, ongoing research is needed to better understand their mechanisms of action compared to traditional adjuvants, and to explore their full potential in clinical vaccine development.

Click here to access the full scientific paper.  

Recent Posts

Start typing and press Enter to search